文献速递产科母胎医学

妊娠期急性脂肪肝86例临床分析

[Clinical analysis of 86 cases of acute fatty liver of pregnancy].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2023-01-01

回顾性分析2017年9月至2022年8月广州医科大学附属第三医院86例妊娠期急性脂肪肝(AFLP)孕妇的临床资料,总结其临床特点及母儿预后。AFLP孕妇以消化道症状为主,肝肾功能损害和凝血功能异常发生率高,但影像学提示脂肪肝者仅27.9%。AFLP对母儿危害大,应重视临床表现及实验室检查,尽早诊断、积极治疗。

要点

  • AFLP孕妇主诉以消化道症状为主,上腹痛68.6%、恶心47.7%、纳差46.5%、呕吐39.5%,17.4%无明显症状。
  • 肝肾功能损害和凝血功能异常发生率高,但仅27.9%(24/86)影像学检查提示脂肪肝。
  • 肾功能不全95.3%、早产46.5%、重症监护病房转入率66.3%,孕妇死亡2.3%,新生儿死亡2.8%。

核心结论

  • AFLP是一种严重的产科并发症,对母儿危害性大,临床诊治中应重视孕妇的临床表现及实验室检查,尽早诊断、积极治疗,以改善母儿结局。

研究设计与样本

  • 回顾性分析2017年9月至2022年8月广州医科大学附属第三医院收治的86例AFLP孕妇的临床资料,分析其一般资料、临床特点、实验室检查及母儿结局。

主要发现

  • 86例AFLP孕妇年龄(30.8±5.4)岁,体重指数(21.0±2.5)kg/m2;初产妇50例(58.1%,50/86),经产妇36例(41.9%,36/86);单胎64例(74.4%,64/86),双胎22例(25.6%,22/86)。
  • 主诉以上腹痛(68.6%,59/86)、恶心(47.7%,41/86)、纳差(46.5%,40/86)、呕吐(39.5%,34/86)为主;皮肤和(或)巩膜黄染54.7%(47/86)、水肿38.4%(33/86)、乏力19.8%(17/86)、出血倾向16.3%(14/86)、多饮或多尿14.0%(12/86)、皮肤瘙痒8.1%(7/86),17.4%(15/86)无明显症状。
  • 肝肾功能损害、凝血功能异常发生率高,血氨、乳酸脱氢酶及乳酸水平升高,血红蛋白、血小板和白蛋白水平降低,仅24例(27.9%,24/86)影像学检查提示脂肪肝。
  • 妊娠合并症或并发症:肾功能不全95.3%(82/86)、早产46.5%(40/86)、妊娠期高血压疾病30.2%(26/86)、妊娠合并糖尿病36.0%(31/86)、胎儿窘迫24.4%(21/86)、肺部感染23.3%(20/86)、弥漫性血管内凝血16.3%(14/86)、多器官功能障碍综合征16.3%(14/86)、肝性脑病9.3%(8/86)、胎儿宫内死亡2.3%(2/86)。
  • 重症监护病房转入率66.3%(57/86),82例好转出院,2例转外院后续治疗,2例(2.3%,2/86)死亡;除外2例胎儿宫内死亡,共分娩新生儿106例,新生儿窒息39例(36.8%,39/106),转入新生儿重症监护病房63例(59.4%,63/106),新生儿死亡3例(2.8%,3/106)。

临床怎么用

  • 作者认为,临床诊治过程中应重视AFLP孕妇的临床表现及实验室检查,尽早诊断、积极治疗,以改善母儿结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical characteristics and maternal and fetal prognosis of pregnant women with acute fatty liver of pregnancy (AFLP). Methods: The clinical data of 86 AFLP pregnant women admitted to the Third Affiliated Hospital of Guangzhou Medical University from September 2017 to August 2022 were collected, and their general data, clinical characteristics, laboratory tests and maternal and fetal outcomes were retrospectively analyzed. Results: (1) General information: the age of the 86 pregnant women with AFLP was (30.8±5.4) years, and the body mass index was (21.0±2.5) kg/m2. There were 50 primiparas (58.1%, 50/86) and 36 multiparas (41.9%, 36/86). There were 64 singleton pregnancies (74.4%, 64/86) and 22 twin pregnancies (25.6%, 22/86). (2) Clinical characteristics: the main complaints of AFLP pregnant women were gastrointestinal symptoms, including epigastric pain (68.6%, 59/86), nausea (47.7%, 41/86), anorexia (46.5%, 40/86), vomiting (39.5%, 34/86). The main non-gastrointestinal symptoms were jaundice of skin and/or scleral (54.7%, 47/86), edema (38.4%, 33/86), fatigue (19.8%, 17/86), bleeding tendency (16.3%, 14/86), polydipsia or polyuria (14.0%, 12/86), skin itching (8.1%, 7/86), and 17.4% (15/86) AFLP pregnant women had no obvious symptoms. (3) Laboratory tests: the incidence of liver and kidney dysfunction and abnormal coagulation function in AFLP pregnant women was high, and the levels of blood ammonia, lactate dehydrogenase and lactic acid were increased, and the levels of hemoglobin, platelet and albumin decreased. However, only 24 cases (27.9%, 24/86) of AFLP pregnant women showed fatty liver by imageology examination. (4) Pregnancy outcomes: ① AFLP pregnant women had a high incidence of pregnancy complications, mainly including renal insufficiency (95.3%, 82/86), preterm birth (46.5%, 40/86), hypertensive disorders in pregnancy (30.2%, 26/86), gestational diabetes mellitus (36.0%, 31/86), fetal distress (24.4%, 21/86), pulmonary infection (23.3%, 20/86), disseminated intravascular coagulation (16.3%, 14/86), multiple organ dysfunction syndrome (16.3%, 14/86), hepatic encephalopathy (9.3%, 8/86), and intrauterine fetal death (2.3%, 2/86). ② Treatment and outcome of AFLP pregnant women: the intensive care unit transfer rate of AFLP pregnant women was 66.3% (57/86). 82 cases were improved and discharged after treatment, 2 cases were transferred to other hospitals for follow-up treatment, and 2 cases (2.3%, 2/86) died. ③ Neonatal outcomes: except for 2 cases of intrauterine death, a total of 106 neonates were delivered, including 39 cases (36.8%, 39/106) of neonatal asphyxia, 63 cases (59.4%, 63/106) of neonatal intensive care unit admission, and 3 cases (2.8%, 3/106) of neonatal death. Conclusions: AFLP is a severe obstetric complication, which is harmful to mother and fetus. In the process of clinical diagnosis and treatment, attention should be paid to the clinical manifestations and laboratory tests of pregnant women, early diagnosis and active treatment, so as to improve maternal and fetal outcomes. 目的: 探讨妊娠期急性脂肪肝(AFLP)孕妇的临床特点及母儿预后。 方法: 收集2017年9月至2022年8月广州医科大学附属第三医院收治的86例AFLP孕妇的临床资料,对其一般资料、临床特点、实验室检查及母儿结局进行回顾性分析。 结果: (1)一般情况:86例AFLP孕妇的年龄为(30.8±5.4)岁,体重指数为(21.0±2.5)kg/m2;初产妇50例(58.1%,50/86),经产妇36例(41.9%,36/86);单胎妊娠64例(74.4%,64/86),双胎妊娠22例(25.6%,22/86)。(2)临床特点:AFLP孕产妇的主诉以消化道症状为主,包括上腹痛(68.6%,59/86)、恶心(47.7%,41/86)、纳差(46.5%,40/86)、呕吐(39.5%,34/86),非消化道症状主要为皮肤和(或)巩膜黄染(54.7%,47/86)、水肿(38.4%,33/86)、乏力(19.8%,17/86)、出血倾向(16.3%,14/86)、多饮或多尿(14.0%,12/86),皮肤瘙痒(8.1%,7/86),另有17.4%(15/86)AFLP孕妇无明显症状。(3)实验室检查:AFLP孕妇肝肾功能损害、凝血功能异常的发生率高,血氨、乳酸脱氢酶及乳酸水平升高,血红蛋白、血小板和白蛋白水平降低,但仅有24例(27.9%,24/86)AFLP孕妇影像学检查提示脂肪肝。(4)妊娠结局:①AFLP孕妇的妊娠合并症或并发症发生率高,主要包括:肾功能不全(95.3%,82/86)、早产(46.5%,40/86)、妊娠期高血压疾病(30.2%,26/86)、妊娠合并糖尿病(36.0%,31/86)、胎儿窘迫(24.4%,21/86)、肺部感染(23.3%,20/86)、弥漫性血管内凝血(16.3%,14/86)、多器官功能障碍综合征(16.3%,14/86)、肝性脑病(9.3%,8/86)、胎儿宫内死亡(2.3%,2/86)。②AFLP孕妇的治疗及转归:AFLP孕妇的重症监护病房转入率为66.3%(57/86),82例经治疗后病情好转出院,2例转外院进行后续治疗,2例(2.3%,2/86)死亡。③新生儿结局:除外2例胎儿宫内死亡,共分娩新生儿106例,发生新生儿窒息39例(36.8%,39/106),转入新生儿重症监护病房63例(59.4%,63/106),新生儿死亡3例(2.8%,3/106)。 结论: AFLP是一种严重的产科并发症,对母儿危害性大,在临床诊治过程中,应重视孕妇的临床表现及实验室检查,尽早诊断、积极治疗,以改善母儿结局。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu CL, Chen DJ, Chen CY, et al. [Clinical analysis of 86 cases of acute fatty liver of pregnancy]. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 38123195. doi:10.3760/cma.j.cn112141-20230814-00047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。